bcbs glp-1 coverage 2025 insurance dropping glp1 : r/Zepbound Navigating Changes to GLP-1 Medication

WHO Guidelines

We can't wait to welcome our speaker faculty: Raveena Asquith-Bhondi, PhD Adriana Ramos Alok Pachori Belle van Rosmalen Kristin Fiorino Maria Trujillo Rosemarie Sellati Fady Botros Allison Goldfine Cecilie Heerdegen Jepsen

The glucagon-like peptide-1 receptor (GLP-1R) plays a central role in metabolic regulation and is a major therapeutic target for obesity and diabetes

A board-certified physician's guide to GLP-1 weight loss medications in 2026, including Foundayo (orforglipron), the first oral GLP-1 without fasting restrictions.

(Online Medical Consultation Required)

The GLP-1 receptor agonist semaglutide reduces risks of kidney function loss, kidney failure, cardiovascular events, cardiovascular death and all-cause mortality in people with CKD and T2DM Ongoing clinical and mechanistic studies are expected to expand use of GLP-1 receptor agonists, GLP-1/GIP and other metabolic hormones for the treatment of CKD At the moment the most complete data is available for semaglutide from SUSTAIN-6 and FLOW trial which is the only trial with primary renal outcome in T2DM patients out of all GLP-1 RA Very good data for renal outcomes as secondary ones available for GLP-1 RAs dulaglutide and liraglutide and GLP-1/GIP RA tirzepatide, Very interesting and positive data from mechanistic REMODEL trial with semaglutide in T2DM patients presented but not yet published (reduced perirenal fat, rernal fibrosis and much more) Based on following excellent papers: #glp1 #gip #semaglutide #tirzepatide #liraglutide #dulaglutide #kidney #ckd #chronickidneydisease #cardiovascularcomplications